| 000 | 01415 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513225242.0 | ||
| 264 | 0 | _c20010315 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a0165-6147 | ||
| 024 | 7 |
_a10.1016/s0165-6147(00)01571-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRoques, B P | |
| 245 | 0 | 0 |
_aNovel approaches to targeting neuropeptide systems. _h[electronic resource] |
| 260 |
_bTrends in pharmacological sciences _cDec 2000 |
||
| 300 |
_a475-83 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnxiety _xdrug therapy |
| 650 | 0 | 4 |
_aDepression _xdrug therapy |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aEnkephalins _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMetalloendopeptidases _xchemistry |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNeuropeptides _xdrug effects |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 |
_aProtease Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Cholecystokinin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Opioid _xdrug effects |
| 650 | 0 | 4 | _aReward |
| 650 | 0 | 4 |
_aSincalide _xdrug effects |
| 650 | 0 | 4 |
_aSubstance-Related Disorders _xdrug therapy |
| 773 | 0 |
_tTrends in pharmacological sciences _gvol. 21 _gno. 12 _gp. 475-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0165-6147(00)01571-6 _zAvailable from publisher's website |
| 999 |
_c11062429 _d11062429 |
||